 |
 |
||||||
 |
Feedback unseren Kunden |
Ihr Warenkorb
€0.00 (0 artikel)
| |||||
- Pill for chest pains ‘could save 10,000 lives a year’
A pill for chest pains that costs around £10 per week could save the lives of thousands of heart failure patients.
- Low-carb and low-fat diets equally good for weight loss
Both low-fat and low-carb diets work equally well to help people lose weight over two years, new research has shown.
- Hope and controversy over prostate cancer screening
Screening older men with the PSA blood test could cut prostate cancer deaths by around half, according to a new study.
- Antidepressant use rises as recession feeds wave of worry
The number of antidepressants prescribed by the NHS has almost doubled in the last decade, and rose sharply last year as the recession bit, figures reveal.
- Overtime could break your heart
Overtime is bad for the heart, according to researchers who followed the careers of more than 6,000 Whitehall civil servants.
Unsere Rechnungsführung ist zertifiziert durch:
- Somaxon: Readers Respond (Angrily) - TheStreet.com
Somaxon: Readers Respond (Angrily)TheStreet.
- Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with ... - MarketWatch (press release)
Town HallSomaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with .
- Somaxon Pharmaceuticals Reports Second Quarter 2010 Financial Results - MarketWatch (press release)
Somaxon Pharmaceuticals Reports Second Quarter 2010 Financial ResultsMarketWatch (press release)The article entitled 'Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic .
- Stock Alert for Somaxon Pharmaceuticals Inc. Issued by MicroStockProfit - MarketWatch (press release)
Stock Alert for Somaxon Pharmaceuticals Inc.
- Somaxon jumps on Procter & Gamble pact - MarketWatch
Somaxon jumps on Procter & Gamble pactMarketWatch.
|
| Copyright © indiapharmacyonline.com. All rights reserved. |